{"id":"atl-962","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Glucagon receptor antagonists work by blocking the action of glucagon, a hormone that raises blood glucose levels. By inhibiting glucagon, ATL-962 aims to lower blood glucose levels in patients with diabetes.","oneSentence":"ATL-962 is a glucagon receptor antagonist.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:21:57.026Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT00148382","phase":"PHASE1","title":"Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects","status":"COMPLETED","sponsor":"Alizyme","startDate":"2005-04","conditions":"Obesity","enrollment":80},{"nctId":"NCT00156897","phase":"PHASE2","title":"Efficacy and Safety of ATL-962 in Obese Diabetics","status":"COMPLETED","sponsor":"Alizyme","startDate":"2004-12","conditions":"Non-Insulin-Dependent Diabetes Mellitus, Obesity","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ATL-962","genericName":"ATL-962","companyName":"Alizyme","companyId":"alizyme","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ATL-962 is a glucagon receptor antagonist. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}